← Leaderboards
Michael C Haffner
Fred Hutchinson Cancer Center
$1,349,187
Attributed
$2,043,303
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,043,303 · 2
By mechanism
R37$1,388,233 · 1
P01$655,070 · 1
Top collaborators
- Michael T Schweizer2 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Peter S Nelson$31,175,698
- Andrew Caleb Hsieh$6,779,569
- Damian J. Green$13,222,447
- Hans-Peter Kiem$98,160,227
- Roland Bruno Walter$12,142,218
Others in their field
Other Rising Stars on “Tissues”
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Mariet Allen · Mayo Clinic Jacksonville$9,602,417
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
TissuesCessation Of LifeMolecularSiteEpigenetic ProcessTumorLinkMetastatic Prostate CancerResistanceSignal TransductionAndrogen Independent Prostate CancerBiomarker DevelopmentDesignDiagnosticDependenceIn VivoCancer EtiologyMalignant Neoplasm Of ProstateAutopsyProgramsResistance MechanismResponseEfficacy EvaluationDeposition
Grant awards (3)
Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy$668,068
R37 · FY2025 · CA · contact PI
Molecular Transitions Driving AR Loss in Double Negative Prostate Cancer$655,070
P01 · FY2025 · CA · contact PI
Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy$720,165
R37 · FY2024 · CA · contact PI